Ardevora Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$14M Sell
23,952
-11,228
-32% -$6.55M 1.24% 23
2023
Q3
$18.9M Sell
35,180
-42,943
-55% -$22.1M 0.93% 38
2023
Q2
$36.6M Sell
78,123
-81,400
-51% -$34.1M 0.89% 44
2023
Q1
$54.8M Buy
159,523
+19,468
+14% +$6.57M 0.98% 33
2022
Q4
$51.2M Sell
140,055
-25,745
-16% -$9.13M 0.87% 37
2022
Q3
$53.6M Sell
165,800
-10,400
-6% -$3.3M 0.97% 29
2022
Q2
$57.1M Buy
+176,200
New +$52.9M 0.94% 15

Other funds holding LLY

Ardevora Asset Management's LLY Position: Q4 2023 in Review

Ardevora Asset Management reduced its Eli Lilly (LLY) stake by 32% in Q4 2023, selling an estimated $6.55M and leaving 23,952 shares worth $14M. The position accounts for 1.24% of the portfolio, ranked #23.

Ardevora Asset Management first reported a position in LLY in Q2 2022 and has held it in 7 quarters since. The position peaked at $57.1M in Q2 2022. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Ardevora Asset Management held 23,952 shares of Eli Lilly worth $14M as of Q4 2023.
  • Ardevora Asset Management sold 11,228 Eli Lilly shares in Q4 2023, an estimated $6.55M.
  • Eli Lilly made up 1.24% of Ardevora Asset Management's portfolio in Q4 2023, its #23 holding.
  • Ardevora Asset Management first reported a position in Eli Lilly in Q2 2022 and has held it in 7 quarters since.
  • Ardevora Asset Management's Eli Lilly position peaked at $57.1M in Q2 2022.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Ardevora Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.